Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
03/31/2025
03/31/2024
03/31/2023
03/31/2022
03/31/2021
Revenue
1
1
1
1
2
4
Revenue Growth (YoY)
0%
0%
0%
-50%
-50%
-20%
Cost of Revenue
1
1
1
1
1
1
Gross Profit
0
0
0
0
1
2
Selling, General & Admin
8
1
2
5
6
5
Research & Development
--
0
--
--
--
--
Operating Expenses
8
2
2
5
6
5
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
-8
-3
-3
-5
-5
-2
Income Tax Expense
--
0
0
0
0
0
Net Income
-8
-3
-3
-5
-5
-2
Net Income Growth
-260%
0%
-40%
0%
150%
-80%
Shares Outstanding (Diluted)
0.77
1.42
0.1
0.03
0
0
Shares Change (YoY)
28,563%
1,213%
225%
542%
44%
125%
EPS (Diluted)
-11.46
-2.32
-28.57
-177.7
-1,103.84
-763.88
EPS Growth
-101%
-92%
-84%
-84%
45%
-88%
Free Cash Flow
-2
-2
-1
0
0
-1
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
0%
0%
0%
0%
50%
50%
Operating Margin
-800%
-100%
-200%
-500%
-250%
-50%
Profit Margin
-800%
-300%
-300%
-500%
-250%
-50%
Free Cash Flow Margin
-200%
-200%
-100%
0%
0%
-25%
EBITDA
-8
-1
-2
-5
-5
-2
EBITDA Margin
-800%
-100%
-200%
-500%
-250%
-50%
D&A For EBITDA
0
0
0
0
0
0
EBIT
-8
-1
-2
-5
-5
-2
EBIT Margin
-800%
-100%
-200%
-500%
-250%
-50%
Effective Tax Rate
--
0%
0%
0%
0%
0%
Follow-Up Questions
What are China SXT Pharmaceuticals Inc's key financial statements?
What are the key financial ratios for SXTC?
How is China SXT Pharmaceuticals Inc's revenue broken down by segment or geography?
Is China SXT Pharmaceuticals Inc profitable?
Does China SXT Pharmaceuticals Inc have any liabilities?
How many outstanding shares for China SXT Pharmaceuticals Inc?
Key Stats
Prev.Close
$2.63
Open
$2.55
Day's Range
$2.49 - $2.83
52 week range
$2.33 - $1,047
Volume
233.3K
Avg.Volume
268.2K
EPS (TTM)
-3.11
Dividend yield
--
Market Cap
$310.9M
What is SXTC?
China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). The company is headquartered in Taizhou, Jiangsu and currently employs 75 full-time employees. The company went IPO on 2019-01-04. The firm sells different types of TCMP products, including Advanced TCMP and Regular TCMP. Advanced TCMP comprises of Directly-Oral-TCMP and After-Soaking-Oral TCMP. Regular TCMP is mainly for hospitals and drug stores for the treatment of various diseases or serving as dietary supplements. The firm sells its products under the brand Suxuantang.